Genmab A/S (CPH: GMAB)
Denmark
· Delayed Price · Currency is DKK 1,873.50
-4.00 (-0.21%)
Aug 30, 2024, 4:59 PM CET
Genmab Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 19,016 | 16,474 | 14,505 | 8,417 | 10,111 | 5,366 | Upgrade
|
| Revenue Growth (YoY) | 17.19% | 13.57% | 72.33% | -16.75% | 88.43% | 77.39% | Upgrade
|
| Cost of Revenue | 580 | 226 | - | - | - | - | Upgrade
|
| Gross Profit | 18,436 | 16,248 | 14,505 | 8,417 | 10,111 | 5,366 | Upgrade
|
| Selling, General & Admin | 3,470 | 3,297 | 2,676 | 1,283 | 661 | 342 | Upgrade
|
| Research & Development | 8,773 | 7,630 | 5,524 | 4,181 | 3,137 | 2,386 | Upgrade
|
| Operating Expenses | 12,243 | 10,927 | 8,200 | 5,464 | 3,798 | 2,728 | Upgrade
|
| Operating Income | 6,193 | 5,321 | 6,305 | 2,953 | 6,313 | 2,638 | Upgrade
|
| Interest Expense | -35 | -27 | -21 | -13 | -10 | -7 | Upgrade
|
| Interest & Investment Income | 1,120 | 939 | 324 | 197 | 184 | 120 | Upgrade
|
| Currency Exchange Gain (Loss) | 279 | -889 | 1,034 | 1,470 | -1,456 | 99 | Upgrade
|
| EBT Excluding Unusual Items | 7,557 | 5,344 | 7,642 | 4,607 | 5,031 | 2,850 | Upgrade
|
| Gain (Loss) on Sale of Investments | 279 | 293 | -659 | -689 | 873 | 9 | Upgrade
|
| Asset Writedown | -64 | - | -38 | - | - | - | Upgrade
|
| Pretax Income | 7,520 | 5,637 | 6,945 | 3,918 | 5,904 | 2,859 | Upgrade
|
| Income Tax Expense | 1,980 | 1,285 | 1,493 | 961 | 1,146 | 693 | Upgrade
|
| Earnings From Continuing Operations | 5,540 | 4,352 | 5,452 | 2,957 | 4,758 | 2,166 | Upgrade
|
| Net Income | 5,540 | 4,352 | 5,452 | 2,957 | 4,758 | 2,166 | Upgrade
|
| Net Income to Common | 5,540 | 4,352 | 5,452 | 2,957 | 4,758 | 2,166 | Upgrade
|
| Net Income Growth | 19.37% | -20.18% | 84.38% | -37.85% | 119.67% | 47.15% | Upgrade
|
| Shares Outstanding (Basic) | 65 | 65 | 65 | 65 | 65 | 63 | Upgrade
|
| Shares Outstanding (Diluted) | 66 | 66 | 66 | 66 | 66 | 64 | Upgrade
|
| Shares Change (YoY) | -0.51% | -0.14% | -0.05% | 0.24% | 3.53% | 2.57% | Upgrade
|
| EPS (Basic) | 85.11 | 66.64 | 83.38 | 45.22 | 73.00 | 34.40 | Upgrade
|
| EPS (Diluted) | 84.41 | 66.02 | 82.59 | 44.77 | 72.21 | 34.03 | Upgrade
|
| EPS Growth | 19.99% | -20.06% | 84.48% | -38.00% | 112.20% | 43.40% | Upgrade
|
| Free Cash Flow | 6,515 | 7,014 | 3,595 | 1,976 | 6,126 | 1,247 | Upgrade
|
| Free Cash Flow Per Share | 99.28 | 106.41 | 54.46 | 29.92 | 92.98 | 19.60 | Upgrade
|
| Gross Margin | 96.95% | 98.63% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | 32.57% | 32.30% | 43.47% | 35.08% | 62.44% | 49.16% | Upgrade
|
| Profit Margin | 29.13% | 26.42% | 37.59% | 35.13% | 47.06% | 40.37% | Upgrade
|
| Free Cash Flow Margin | 34.26% | 42.58% | 24.78% | 23.48% | 60.59% | 23.24% | Upgrade
|
| EBITDA | 6,463 | 5,561 | 6,521 | 3,147 | 6,543 | 2,777 | Upgrade
|
| EBITDA Margin | 33.99% | 33.76% | 44.96% | 37.39% | 64.71% | 51.75% | Upgrade
|
| D&A For EBITDA | 270 | 240 | 216 | 194 | 230 | 139 | Upgrade
|
| EBIT | 6,193 | 5,321 | 6,305 | 2,953 | 6,313 | 2,638 | Upgrade
|
| EBIT Margin | 32.57% | 32.30% | 43.47% | 35.08% | 62.44% | 49.16% | Upgrade
|
| Effective Tax Rate | 26.33% | 22.80% | 21.50% | 24.53% | 19.41% | 24.24% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.